Christopher Baker

1.2k total citations
43 papers, 746 citations indexed

About

Christopher Baker is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Christopher Baker has authored 43 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Dermatology, 20 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Christopher Baker's work include Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (16 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Christopher Baker is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (16 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Christopher Baker collaborates with scholars based in Australia, New Zealand and United States. Christopher Baker's co-authors include Peter Foley, Marius Rademaker, Eugene Tan, John Sullivan, George F. Sheldon, Boni E. Elewski, Jeffrey Crowley, Martin M. Okun, Yves Poulin and Phoebe Rich and has published in prestigious journals such as Journal of the American College of Cardiology, Critical Care Medicine and Journal of the American Academy of Dermatology.

In The Last Decade

Christopher Baker

38 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Baker Australia 18 382 312 111 96 89 43 746
Annunziata Raimondo Italy 15 394 1.0× 378 1.2× 109 1.0× 88 0.9× 53 0.6× 46 791
Lindsay C. Strowd United States 17 501 1.3× 135 0.4× 127 1.1× 145 1.5× 88 1.0× 94 957
Stephanie T. Le United States 12 256 0.7× 133 0.4× 177 1.6× 56 0.6× 143 1.6× 47 686
Meral Ekşioğlu Türkiye 14 251 0.7× 153 0.5× 133 1.2× 93 1.0× 32 0.4× 65 727
Francisco Gómez‐García Spain 19 246 0.6× 407 1.3× 69 0.6× 140 1.5× 69 0.8× 47 1.0k
Girish Gupta India 14 261 0.7× 168 0.5× 88 0.8× 25 0.3× 93 1.0× 103 847
A. Soria France 17 444 1.2× 114 0.4× 76 0.7× 195 2.0× 145 1.6× 86 970
Maria Suprun United States 19 661 1.7× 351 1.1× 100 0.9× 134 1.4× 72 0.8× 41 1.5k
N. Bénéton France 16 275 0.7× 352 1.1× 168 1.5× 101 1.1× 101 1.1× 64 877
Scott A. Elman United States 9 310 0.8× 134 0.4× 101 0.9× 167 1.7× 44 0.5× 42 603

Countries citing papers authored by Christopher Baker

Since Specialization
Citations

This map shows the geographic impact of Christopher Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Baker more than expected).

Fields of papers citing papers by Christopher Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Baker. The network helps show where Christopher Baker may publish in the future.

Co-authorship network of co-authors of Christopher Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Baker. A scholar is included among the top collaborators of Christopher Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Baker. Christopher Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rademaker, Marius, Peter Foley, John Sullivan, et al.. (2024). Pharmaceutical Management of Rosacea—An Australian/New Zealand Medical Dermatology Consensus Narrative. Dermatologic Therapy. 2024(1).
3.
Mahar, Patrick, Susan J. Robertson, David Orchard, Christopher Baker, & Peter Foley. (2024). Paediatric indications and dosing guidance for advanced targeted treatments in Australia. Australasian Journal of Dermatology. 65(4). 373–377.
5.
Foley, Peter, Kurt Gebauer, John Sullivan, et al.. (2023). Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients. Australasian Journal of Dermatology. 64(4). 476–487. 5 indexed citations
6.
Sullivan, John, et al.. (2023). Real‐world treatment persistence of four commonly prescribed biologic therapies for moderate to severe psoriasis in Australia. Australasian Journal of Dermatology. 64(4). 504–513. 2 indexed citations
7.
Jabbour, Richard J., Tushar Kotecha, Luciano Candilio, et al.. (2020). TCT CONNECT-221 Primary PCI for STEMI During the COVID-19 Pandemic in London: A Systematic Analysis of Pathway Activation and Outcomes. Journal of the American College of Cardiology. 76(17). B96–B96. 1 indexed citations
8.
Rademaker, Marius, et al.. (2020). Advice regarding COVID‐19 and use of immunomodulators, in patients with severe dermatological diseases. Australasian Journal of Dermatology. 61(2). 158–159. 25 indexed citations
9.
Yue, Zhilian, et al.. (2018). Three-Dimensional Printing and Cell Therapy for Wound Repair. Advances in Wound Care. 7(5). 145–156. 38 indexed citations
10.
Rademaker, Marius, Diana Rubel, Karen Agnew, et al.. (2018). Psoriasis and cancer. An Australian/New Zealand narrative. Australasian Journal of Dermatology. 60(1). 12–18. 25 indexed citations
11.
Elewski, Boni E., Martin M. Okun, Kim Papp, et al.. (2017). Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology. 78(1). 90–99.e1. 68 indexed citations
12.
Dávila‐Seijo, P., I. García‐Doval, Luigi Naldi, et al.. (2016). Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. Acta Dermato Venereologica. 97(4). 516–518. 2 indexed citations
13.
Kinsella, John P., et al.. (2016). Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia. American Journal of Perinatology. 34(2). 155–163. 42 indexed citations
14.
Ormerod, A.D., Matthias Augustin, Christopher Baker, et al.. (2012). Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies. Dermatology. 224(3). 236–243. 30 indexed citations
15.
Foley, Peter, et al.. (2003). Analysis of patients with suspected photosensitivity referred for investigation to an Australian photodermatology clinic. Journal of the American Academy of Dermatology. 48(5). 714–720. 22 indexed citations
16.
Foley, Peter, et al.. (2003). Chronic actinic dermatitis: A retrospective analysis of 44 cases referred to an Australian photobiology clinic. Australasian Journal of Dermatology. 44(4). 256–262. 28 indexed citations
17.
Foley, Peter, et al.. (2002). Thalidomide experience of a major Australian teaching hospital. Australasian Journal of Dermatology. 43(4). 278–284. 16 indexed citations
18.
Foley, Peter, et al.. (2002). Changes of photosensitivity and action spectrum with time in solar urticaria. Photodermatology Photoimmunology & Photomedicine. 18(4). 191–195. 15 indexed citations
19.
Foley, Peter, et al.. (2002). Actinic prurigo: A retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australasian Journal of Dermatology. 43(2). 128–132. 4 indexed citations
20.
Foley, Peter, et al.. (2002). Actinic prurigo: A retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australasian Journal of Dermatology. 43(2). 128–132. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026